AWARD
65 -- Cell and Recombinant Based Pandemic Influenza Vaccine
- Notice Date
- 5/5/2006
- Notice Type
- Award
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- Department of Health and Human Services, Office of the Secretary, Office of Public Health Emergency Preparedness, Office of Research and Development Coordination 200 Independence Avenue, SW Room 636G, Washington, DC, 20201
- ZIP Code
- 20201
- Solicitation Number
- ORDC-VB-05-04
- Archive Date
- 5/19/2006
- Point of Contact
- David Beck, Chief Contracting Officer, Phone 202-260-9660, Fax 202-690-7412, - Darrick Early, Contract Specialist, Phone 202-401-3693, Fax 202-690-7412,
- E-Mail Address
-
david.beck@hhs.gov, darrick.early@hhs.gov
- Small Business Set-Aside
- N/A
- Award Number
- HHSO100200600010C to HHSO100200600014C
- Award Date
- 5/4/2006
- Awardee
- HHSO100200600010C, MedImmune, Gaithersburg, MD, $169,462,231; HHSO100200600011C, GlaxoSmithKline, Phila., PA, $274,752,168; HHSO100200600012C, Novartis (formerly Chiron), Emeryville, CA, $220,507,491; HHSO100200600013C, DynPort Vaccine, Frederick, MD, $242,582,756 (Incrementally funded at $40,971,895 through 7/31/2007); HHSO100200600014C, Solvay Pharmaceuticals, Marietta, Georgia, $298,594,057
- Award Amount
- $169,462,231 to $298,594,057
- Record
- SN01043187-W 20060507/060505224326 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |